Literature DB >> 30414962

The Antibody Light-Chain Linker Regulates Domain Orientation and Amyloidogenicity.

Benedikt Weber1, Manuel Hora1, Pamina Kazman1, Christoph Göbl2, Carlo Camilloni3, Bernd Reif1, Johannes Buchner4.   

Abstract

The antibody light chain (LC) consists of two domains and is essential for antigen binding in mature immunoglobulins. The two domains are connected by a highly conserved linker that comprises the structurally important Arg108 residue. In antibody light chain (AL) amyloidosis, a severe protein amyloid disease, the LC and its N-terminal variable domain (VL) convert to fibrils deposited in the tissues causing organ failure. Understanding the factors shaping the architecture of the LC is important for basic science, biotechnology and for deciphering the principles that lead to fibril formation. In this study, we examined the structure and properties of LC variants with a mutated or extended linker. We show that under destabilizing conditions, the linker modulates the amyloidogenicity of the LC. The fibril formation propensity of LC linker variants and their susceptibility to proteolysis directly correlate implying an interplay between the two LC domains. Using NMR and residual dipolar coupling-based simulations, we found that the linker residue Arg108 is a key factor regulating the relative orientation of the VL and CL domains, keeping them in a bent and dense, but still flexible conformation. Thus, inter-domain contacts and the relative orientation of VL and CL to each other are of major importance for maintaining the structural integrity of the full-length LC.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  amyloid; antibody folding; intramolecular interactions; light chain linker; protein stability

Mesh:

Substances:

Year:  2018        PMID: 30414962     DOI: 10.1016/j.jmb.2018.10.024

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  10 in total

1.  A Conservative Point Mutation in a Dynamic Antigen-binding Loop of Human Immunoglobulin λ6 Light Chain Promotes Pathologic Amyloid Formation.

Authors:  Daniele Peterle; Elena S Klimtchuk; Thomas E Wales; Florian Georgescauld; Lawreen H Connors; John R Engen; Olga Gursky
Journal:  J Mol Biol       Date:  2021-10-19       Impact factor: 5.469

2.  An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis.

Authors:  Alice Nevone; Maria Girelli; Silvia Mangiacavalli; Bruno Paiva; Paolo Milani; Pasquale Cascino; Maggie Piscitelli; Valentina Speranzini; Claudio Salvatore Cartia; Pietro Benvenuti; Ibai Goicoechea; Francesca Fazio; Marco Basset; Andrea Foli; Martina Nanci; Giulia Mazzini; Serena Caminito; Melania Antonietta Sesta; Simona Casarini; Paola Rognoni; Francesca Lavatelli; Maria Teresa Petrucci; Pier Paolo Olimpieri; Stefano Ricagno; Luca Arcaini; Giampaolo Merlini; Giovanni Palladini; Mario Nuvolone
Journal:  Leukemia       Date:  2022-05-24       Impact factor: 12.883

3.  Protease-sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregation.

Authors:  Giulia Mazzini; Stefano Ricagno; Serena Caminito; Paola Rognoni; Paolo Milani; Mario Nuvolone; Marco Basset; Andrea Foli; Rosaria Russo; Giampaolo Merlini; Giovanni Palladini; Francesca Lavatelli
Journal:  FEBS J       Date:  2021-09-15       Impact factor: 5.622

4.  Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.

Authors:  Pamina Kazman; Marie-Theres Vielberg; María Daniela Pulido Cendales; Lioba Hunziger; Benedikt Weber; Ute Hegenbart; Martin Zacharias; Rolf Köhler; Stefan Schönland; Michael Groll; Johannes Buchner
Journal:  Elife       Date:  2020-03-10       Impact factor: 8.140

5.  Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient.

Authors:  Paolo Swuec; Francesca Lavatelli; Masayoshi Tasaki; Cristina Paissoni; Paola Rognoni; Martina Maritan; Francesca Brambilla; Paolo Milani; Pierluigi Mauri; Carlo Camilloni; Giovanni Palladini; Giampaolo Merlini; Stefano Ricagno; Martino Bolognesi
Journal:  Nat Commun       Date:  2019-03-20       Impact factor: 14.919

6.  Effect of Single Amino Acid Substitutions by Asn and Gln on Aggregation Properties of Bence-Jones Protein BIF.

Authors:  Maria Timchenko; Azat Abdullatypov; Hiroshi Kihara; Alexander Timchenko
Journal:  Int J Mol Sci       Date:  2019-10-20       Impact factor: 5.923

7.  Breakdown of supersaturation barrier links protein folding to amyloid formation.

Authors:  Masahiro Noji; Tatsushi Samejima; Keiichi Yamaguchi; Masatomo So; Keisuke Yuzu; Eri Chatani; Yoko Akazawa-Ogawa; Yoshihisa Hagihara; Yasushi Kawata; Kensuke Ikenaka; Hideki Mochizuki; József Kardos; Daniel E Otzen; Vittorio Bellotti; Johannes Buchner; Yuji Goto
Journal:  Commun Biol       Date:  2021-01-26

8.  Dissection of the amyloid formation pathway in AL amyloidosis.

Authors:  Pamina Kazman; Ramona M Absmeier; Harald Engelhardt; Johannes Buchner
Journal:  Nat Commun       Date:  2021-11-11       Impact factor: 14.919

9.  Biochemical and biophysical characterisation of immunoglobulin free light chains derived from an initially unbiased population of patients with light chain disease.

Authors:  Rebecca Sternke-Hoffmann; Amelie Boquoi; David Lopez Y Niedenhoff; Florian Platten; Roland Fenk; Rainer Haas; Alexander K Buell
Journal:  PeerJ       Date:  2020-03-17       Impact factor: 2.984

10.  Cu(II) Binding Increases the Soluble Toxicity of Amyloidogenic Light Chains.

Authors:  Rosaria Russo; Margherita Romeo; Tim Schulte; Martina Maritan; Luca Oberti; Maria Monica Barzago; Alberto Barbiroli; Carlo Pappone; Luigi Anastasia; Giovanni Palladini; Luisa Diomede; Stefano Ricagno
Journal:  Int J Mol Sci       Date:  2022-01-16       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.